High Therapeutic Potential for Systemic Delivery of a Liposomeconjugated Herpes Simplex Virus

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|1|111-122

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.1, 2011-01, pp. : 111-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prophylactic Vaccine Strategies and the Potential of Therapeutic Vaccines Against Herpes Simplex Virus

By  

Current Pharmaceutical Design, Vol. 13, Iss. 19, 2007-07 ,pp. : 1975-1988

Bentham Science Publishers

Access to resources Recommend Favorite

Engineered herpes simplex virus vectors for antitumor therapy and vaccine delivery

By Gaston David C   Whitley Richard J   Parker Jacqueline N  

Future Virology, Vol. 6, Iss. 3, 2011-03 ,pp. : 321-340

Future Medicine

Access to resources Recommend Favorite

Herpes Simplex Virus Vectors for Gene Delivery to a Variety of Different Cell Types

By  

Current Gene Therapy, Vol. 2, Iss. 4, 2002-12 ,pp. : 415-426

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical and Therapeutic Issues for Herpes Simplex Virus-2 and HIV Co-Infection

By Lingappa Jairam R.  

Drugs, Vol. 67, Iss. 2, 2007-01 ,pp. : 155-174

Adis International

Access to resources Recommend Favorite

Host responses to herpes simplex virus and herpes simplex virus vectors

By Hukkanen Veijo   Paavilainen Henrik   Mattila Riikka K  

Future Virology, Vol. 5, Iss. 4, 2010-07 ,pp. : 493-512

Future Medicine

Access to resources Recommend Favorite